Hwashin Tech "Acquires Genome Biologics Asia Pacific Shares for 5 Billion KRW"
[Asia Economy Reporter Seungjin Lee] Hwashin Tech announced on the 27th that it will acquire 47,394 shares of reagent research and development company Genome Biologics Asia Pacific for approximately 5 billion KRW.
After acquiring the shares, Hwashin Tech's stake in Genome Biologics Asia Pacific will be 21.2%. The scheduled date of share acquisition is the same day as the announcement.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Looks Even More Like Him in Person": Albino Water Buffalo with Golden Hair and Pink Skin Nicknamed 'Trump'
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Hwashin Tech stated that the purpose of this share acquisition is "business diversification and revenue diversification through entry into new business areas."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
